Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Autor: Gauckler, Philipp1 (AUTHOR) philipp.gauckler@i-med.ac.at, Shin, Jae Il2,3,4 (AUTHOR), Alberici, Federico5,6 (AUTHOR), Audard, Vincent7 (AUTHOR), Bruchfeld, Annette8,9 (AUTHOR), Busch, Martin10 (AUTHOR), Cheung, Chee Kay11,12 (AUTHOR), Crnogorac, Matija13 (AUTHOR), Delbarba, Elisa14 (AUTHOR), Eller, Kathrin15 (AUTHOR), Faguer, Stanislas16,17 (AUTHOR), Galesic, Kresimir13 (AUTHOR), Griffin, Siân18 (AUTHOR), Hrušková, Zdenka19 (AUTHOR), Jeyabalan, Anushya20 (AUTHOR), Karras, Alexandre21 (AUTHOR), King, Catherine22 (AUTHOR), Kohli, Harbir Singh23 (AUTHOR), Maas, Rutger24 (AUTHOR), Mayer, Gert1 (AUTHOR)
Zdroj: Autoimmunity Reviews. Nov2020, Vol. 19 Issue 11, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: